Chimeric Therapeutics Ltd
ASX:CHM
Chimeric Therapeutics Ltd
ASX:CHM
Price:
0.0025
AUD
Market Closed
Market Cap:
AU$9.1m
Cash Flow Statement
Cash Flow Statement
Chimeric Therapeutics Ltd
Chimeric Therapeutics Ltd
Currency: AUD
| Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||
| Stock-Based Compensation |
3
|
5
|
3
|
2
|
1
|
1
|
1
|
|
| Change in Working Capital |
(0)
|
0
|
4
|
9
|
13
|
12
|
8
|
|
| Cash from Operating Activities |
(13)
N/A
|
(20)
-49%
|
(16)
+17%
|
(8)
+49%
|
(8)
+9%
|
(6)
+27%
|
(7)
-32%
|
|
| Investing Cash Flow | ||||||||
| Capital Expenditures |
(1)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
|
| Other Items |
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(1)
N/A
|
(0)
+85%
|
(0)
-32%
|
(0)
+7%
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Financing Cash Flow | ||||||||
| Net Issuance of Common Stock |
15
|
0
|
3
|
10
|
12
|
9
|
8
|
|
| Net Issuance of Debt |
(4)
|
(4)
|
(2)
|
(1)
|
(2)
|
(1)
|
0
|
|
| Other |
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
2
|
|
| Cash from Financing Activities |
10
N/A
|
9
-2%
|
0
-97%
|
8
+3 199%
|
8
-1%
|
7
-16%
|
10
+44%
|
|
| Change in Cash | ||||||||
| Effect of Foreign Exchange Rates |
0
|
1
|
0
|
(0)
|
(0)
|
0
|
(0)
|
|
| Net Change in Cash |
(4)
N/A
|
(10)
-143%
|
(16)
-63%
|
(0)
+99%
|
1
N/A
|
2
+123%
|
3
+75%
|
|
| Free Cash Flow | ||||||||
| Free Cash Flow |
(14)
N/A
|
(20)
-44%
|
(16)
+17%
|
(8)
+49%
|
(8)
+9%
|
(6)
+27%
|
(7)
-32%
|
|
Switch to:
Switch to:
See Also
Discover More
